...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Shareholders
2
Aug 31, 2021 08:04PM
4
Sep 01, 2021 10:38AM
1
Sep 01, 2021 11:36AM

 0.89%  Charalambos Katevatis  1,200,001 $300.0k 0% ???

They're still being confused with this other company!

0.89% Charalambos Katevatis 1,200,001 $300.0k 0%

https://www.pressreader.com/canada/stockwatch-daily/20210819/281505049295814

3
Sep 01, 2021 02:09PM
3
Sep 01, 2021 02:25PM
1
Sep 01, 2021 04:48PM

Sep 01, 2021 05:13PM
1
Sep 01, 2021 05:42PM
1
Sep 01, 2021 07:05PM
1
Sep 01, 2021 07:33PM
2
Sep 01, 2021 11:01PM

Sep 02, 2021 01:03AM
1
Sep 02, 2021 02:31AM

Sep 02, 2021 06:38AM

Sep 02, 2021 10:04AM

Sep 02, 2021 12:01PM
Share
New Message
Please login to post a reply